Loading...
Loading...
CDC PLACES (2023, crude) estimates 10.6% of adults in Mesa have diagnosed diabetes — 1.4 points below the U.S. 12% figure. Census population 504,258. Arizona Medicare wound biologics: Noridian Healthcare Solutions (JF). Hawk Medical is a national HCT/P 361 and wound-care distributor serving licensed Mesa clinics — not a walk-in office.
Written for licensed providers. Reviewed by Joe Bradley, Founder & CEO. Content version 2026-09-18. Hawk Medical ships nationwide — this is not a Mesa storefront.
Growth Factor Therapy for Tissue Repair in Mesa, AZ for clinics & physicians. Growth factor therapy produc… Compliance support & pricing — contact Hawk Medical.
Joe Bradley will tell you the same thing he tells his own staff: epidemiology first, then MAC, then SKU. CDC PLACES (2023, crude) estimates 10.6% of adults in Mesa have diagnosed diabetes — 1.4 points below the U.S. 12% figure. 13% of adults 18–64 here currently lack health insurance (CDC PLACES ACCESS2, 2023). Cash-pay PRP and Medicare CTPs cannot share one consent script. Then we pick growth factor therapy against that mix.
National Growth Factor Therapy for Tissue Repair notes (how the product actually works)JF reviewers still want serial wound measurements and conservative-care history before CTPs, whether diabetes in Mesa is 10.6% or not. PLACES is planning data. The LCD is the claim.
We are not going to invent a Mesa warehouse or a five-star local review. What you get is growth factor therapy from FDA-registered sources, lot paperwork, and someone who has run the same SOPs in clinic — Joe Bradley. The local numbers on this page are CDC PLACES and CMS JF, not marketing adjectives.
CDC PLACES (2023, crude prevalence) estimates 10.6% of adults — 1.4 points below the U.S. 12% figure. Obesity is 30.7%; arthritis is 24.7%. That is place-level BRFSS modeling, not a clinic census and not a Mesa trial.
Yes — receiving, storage, indication, and documentation templates are part of onboarding. SOPs still have to be adopted as the clinic’s own procedures; we do not pretend to be the medical director in Mesa.
No. Hawk Medical does not distribute products as “stem cell therapy.” HCT/P 361 allografts are regulated under 21 CFR 1271 for homologous use and minimal manipulation. PRP is autologous. Marketing that blurs those lanes is a compliance problem in every state, including Arizona.
Often yes, which is the point of vendor consolidation. Keep DME delivery tickets and HCT/P lot files separate so a Arizona audit trail stays clean.
If you operate in Arizona and another MAC state, say it on the first call. JF will not port 1:1. We would rather split utilization than watch a sister clinic copy Mesa tickets into the wrong jurisdiction.
Contact us to learn how Hawk Medical supports practices in Mesa, AZ.
Hawk Medical is a national distributor. Joe Bradley’s clinic uses the same product classes. What is local for Mesa is JF geography and published epidemiology — not a street address.
CDC PLACES 2023 crude rate for Mesa — 1.4 points below the U.S. 12% figure. Planning input, not an outcomes claim.
Arizona Part B wound biologics follow this contractor (siblings: AK, ID, MT, ND, OR, SD, UT, WA, WY). We train to the articles. We do not write coverage.
PLACES crude adult arthritis in Mesa. Useful for joint-program math; still needs a diagnosis and privileging.
No Mesa storefront. Joe Bradley is an active practice owner. growth factor therapy stays in its regulatory lane — not “FDA-approved stem cell therapy.”
Experience the difference of working with a distributor who understands your practice because we operate one ourselves.